ホルモン避妊薬の世界市場レポート 2025年

ホルモン避妊薬市場規模は、今後数年間でわずかな成長が見込まれます。2029年の年間平均成長率（CAGR）は1.9％で、155億3,000万米ドルに成長します。予測期間の成長は、家族計画に対する意識の高まり、研究開発費の増加、医療支出の増加、機関間の協力関係の増加などに起因すると考えられます。予測期間の主要動向としては、より長持ちする膣リングへの投資、服薬アドヒアランスを向上させるAIソリューションへの投資、革新的な新製品の発売、エコフレンドリーエストロゲンプロファイルへの投資、改良型プロゲストゲンのみの避妊薬への投資、長期薬剤送達システムへの投資の継続などが挙げられます。

ホルモン避妊薬をめぐる意識の高まりは、個人の生殖に関する目標やライフスタイルに沿った、十分な情報に基づいた意思決定を行う力を与えています。この意識の高まりにより、個人は家族計画やライフスタイルの嗜好により適した選択をすることができます。2023年9月、世界保健機関（WHO）は、あらゆる方法を含む世界の避妊普及率は2022年に65％に達し、近代的避妊法は結婚している女性の58.7％に達したと報告しました。さらに、女性の家族計画に対する世界の需要は、9億人から2021年には11億人近くに増加し、2022年には15～49歳の女性における世界の満足度は77.5％になると予測されています。こうした意識の高まりが、ホルモン避妊薬市場を大きく後押ししています。

計画外妊娠の割合の高まりは、ホルモン避妊薬市場の成長を促進すると予測されます。望まない妊娠や計画外の妊娠に分類される計画外妊娠は、世界的に大きな課題となっています。ホルモン避妊薬は、計画外の妊娠を防ぐための信頼性が高く便利なソリューションを提供し、個人とカップルに家族計画に関するより大きなコントロールを与えています。2022年3月の国連人口基金によると、世界では毎年1億2,100万件の予定外妊娠が発生しており、アフガニスタンでは2025年に480万件の予定外妊娠が発生すると予測されています。このように、計画外妊娠の増加率がホルモン避妊薬市場の成長を促進すると予想されます。

目次

第1章 エグゼクティブサマリー

第2章 市場の特徴

第3章 市場動向と戦略

第4章 市場：金利、インフレ、地政学、コロナ禍、回復が市場に与える影響を含むマクロ経済シナリオ

第5章 世界の成長分析と戦略分析フレームワーク

• 世界のホルモン避妊薬PESTEL分析（政治、社会、技術、環境、法的要因、促進要因、抑制要因）
• 最終用途産業の分析
• 世界のホルモン避妊薬市場：成長率分析
• 世界のホルモン避妊薬市場の実績：規模と成長、2019～2024年
• 世界のホルモン避妊薬市場の予測：規模と成長、2024～2029年、2034年
• 世界のホルモン避妊薬総アドレス可能市場（TAM）

第6章 市場セグメンテーション

• 世界のホルモン避妊薬市場：製品別、実績と予測、2019～2024年、2024～2029年、2034年
• 錠剤
• 注射による避妊
• 膣リング
• その他
• 世界のホルモン避妊薬市場：エンドユーザー別、実績と予測、2019～2024年、2024～2029年、2034年
• 病院
• 在宅医療
• 婦人科センター
• クリニック
• 外来手術センター
• 世界のホルモン避妊薬市場：ホルモンタイプ別、実績と予測、2019～2024年、2024～2029年、2034年
• プロゲスチンのみ
• 複合ホルモン
• 世界のホルモン避妊薬市場：流通チャネル別、実績と予測、2019～2024年、2024～2029年、2034年
• ドラッグストア
• 婦人科/不妊治療クリニック
• eコマース
• その他
• 世界のホルモン避妊薬市場、錠剤のサブセグメンテーション、タイプ別、実績と予測、2019～2024年、2024～2029年、2034年
• 複合経口避妊薬（COC）
• プロゲスチンのみのピル（POP）
• 緊急避妊薬
• 世界のホルモン避妊薬市場、注射による避妊のサブセグメンテーション、タイプ別、実績と予測、2019～2024年、2024～2029年、2034年
• デポメドロキシプロゲステロン酢酸塩（DMPA）
• 注射による避妊薬
• 皮下インプラント
• 世界のホルモン避妊薬市場、膣リングのサブセグメンテーション、タイプ別、実績と予測、2019～2024年、2024～2029年、2034年
• ヌーバリング
• アノベラ
• その他のホルモン膣リング
• 世界のホルモン避妊薬市場、その他の製品のサブセグメンテーション、タイプ別、実績と予測、2019～2024年、2024～2029年、2034年
• 経皮パッチ
• ホルモンを含む子宮内避妊器具（IUD）
• ホルモンインプラント
• 男性用避妊薬

第7章 地域別・国別分析

• 世界のホルモン避妊薬市場：地域別、実績と予測、2019～2024年、2024～2029年、2034年
• 世界のホルモン避妊薬市場：国別、実績と予測、2019～2024年、2024～2029年、2034年

第8章 アジア太平洋市場

第9章 中国市場

第10章 インド市場

第11章 日本市場

第12章 オーストラリア市場

第13章 インドネシア市場

第14章 韓国市場

第15章 西欧市場

第16章 英国市場

第17章 ドイツ市場

第18章 フランス市場

第19章 イタリア市場

第20章 スペイン市場

第21章 東欧市場

第22章 ロシア市場

第23章 北米市場

第24章 米国市場

第25章 カナダ市場

第26章 南米市場

第27章 ブラジル市場

第28章 中東市場

第29章 アフリカ市場

第30章 競合情勢と企業プロファイル

• ホルモン避妊薬市場：競合情勢
• ホルモン避妊薬市場：企業プロファイル
  • Bayer AG
  • Merck & Co. Inc
  • Viatris
  • Gedeon Richter
  • AbbVie

第31章 その他の大手企業と革新的企業

• Pfizer
• Teva Pharmaceuticals
• Mayne Pharma Group Limited
• Lupin Limited
• HLL Lifecare Limited
• Amneal Pharmaceuticals
• DKT International
• Piramal Pharma Limited
• Allergan
• Afaxys Inc.
• Agile Therapeutic
• Cipla Limited
• Glenmark Pharmaceuticals
• Novartis AG
• Sun Pharmaceutical Industries Ltd.

第32章 世界の市場競合ベンチマーキングとダッシュボード

第33章 主要な合併と買収

第34章 最近の市場動向

第35章 市場の潜在力が高い国、戦略

• ホルモン避妊薬市場、2029年：新たな機会を提供する国
• ホルモン避妊薬市場、2029年：新たな機会を提供するセグメント
• ホルモン避妊薬市場、2029年：成長戦略
  • 市場動向による戦略
  • 競合の戦略

第36章 付録

Hormonal contraceptives are a form of birth control that utilizes hormones to prevent pregnancy. There are various types, some of which are reversible, while others are permanent. Certain varieties may also offer protection against sexually transmitted diseases (STDs).

The primary categories of products in oral contraceptive pills include injectable birth control, emergency contraceptive pills, vaginal rings, and others. Oral contraceptive pills, also known as birth control pills, are a class of synthetic steroid hormones that inhibit the release of follicle-stimulating hormone (FSH) and luteinizing hormone (LH) from the anterior lobe of the pituitary gland in the female body. These pills come in different hormonal compositions, including progestin-only and combined hormones, and find applications in hospitals, homecare settings, gynecology centers, clinics, and ambulatory surgical centers. Distribution channels for these products include drug stores, gynecology or fertility clinics, e-commerce, and others.

The hormonal contraceptives market research report is one of a series of new reports from The Business Research Company that provides hormonal contraceptives market statistics, including hormonal contraceptives industry global market size, regional shares, competitors with a hormonal contraceptives market share, detailed hormonal contraceptives market segments, market trends and opportunities, and any further data you may need to thrive in the hormonal contraceptives industry. This hormonal contraceptive market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The hormonal contraceptives market size has grown marginally in recent years. It will grow from $14.16 billion in 2024 to $14.43 billion in 2025 at a compound annual growth rate (CAGR) of 1.9%. The growth in the historic period can be attributed to government initiatives, increase in use of contraceptives, increase in pharmaceutical r&d expenditure, increased healthcare expenditure and growth in the number of healthcare facilities.

The hormonal contraceptives market size is expected to see marginal growth in the next few years. It will grow to $15.53 billion in 2029 at a compound annual growth rate (CAGR) of 1.9%. The growth in the forecast period can be attributed to the increasing awareness on family planning, increasing research and development spending, rise in healthcare expenditure, increasing collaborations between agencies. Major trends in the forecast period include investing in longer lasting vaginal rings, investing in AI solutions to improve medication adherence, launching new innovative products, investing in environmental friendly estrogen profile, investing in improved progestogen only birth control pills, continue to investing in long-term delivery drugs systems.

The heightened awareness surrounding hormonal contraceptives has empowered individuals to make well-informed decisions aligned with their reproductive goals and lifestyles. This increased awareness enables individuals to make choices that better suit their family planning and lifestyle preferences. In September 2023, the World Health Organization (WHO) reported that global contraception prevalence, including any method, reached 65% in 2022, with modern contraceptive methods at 58.7% among married women in a union. Additionally, the global demand for family planning among women increased from 900 million to nearly 1.1 billion in 2021, with a projected global satisfaction rate of 77.5% among women aged 15-49 in 2022. This elevated awareness significantly propels the hormonal contraceptives market.

The escalating rate of unplanned pregnancies is anticipated to drive the growth of the hormonal contraceptive market. Unplanned pregnancies, categorized as unwanted or unplanned, pose a significant global challenge. Hormonal contraceptives offer a reliable and convenient solution to prevent unplanned pregnancies, giving individuals and couples greater control over family planning. According to the United Nations Population Fund in March 2022, there were 121 million unintended pregnancies globally each year, with Afghanistan projected to experience 4.8 million unintended pregnancies in 2025. Thus, the increasing rate of unplanned pregnancies is expected to fuel the growth of the hormonal contraceptives market.

Companies are innovating by introducing chewable, low-dose oral contraceptives to reduce side effects and enhance daily regimen adherence. The availability of chewable contraceptives as an over-the-counter product aims to improve patient compliance and minimize side effects. Leading companies, such as Lupin Pharmaceuticals, Walter Chilcott, and Watson Pharmaceuticals, are actively participating in this initiative.

Major companies in the hormonal contraceptives market are developing advanced products, such as nonprescription daily oral contraceptives, to improve accessibility and convenience for users. A nonprescription daily oral contraceptive is a type of birth control pill that can be purchased without a prescription from a healthcare provider. For example, in July 2023, Perrigo Company PLC, a US-based manufacturer of private label over-the-counter pharmaceuticals, received approval from the Food and Drug Administration (FDA), a US federal agency responsible for protecting public health, for Opill. Opill is the first nonprescription daily oral contraceptive available to consumers without a prescription. The launch of Opill represents a significant advancement in reproductive health, allowing individuals to access effective birth control without the obstacles of needing a prescription or a healthcare appointment.

Major companies operating in the hormonal contraceptives market include Bayer AG, Merck & Co. Inc, Viatris, Gedeon Richter, AbbVie, Pfizer, Teva Pharmaceuticals, Mayne Pharma Group Limited, Lupin Limited, HLL Lifecare Limited, Amneal Pharmaceuticals, DKT International, Piramal Pharma Limited, Allergan, Afaxys Inc., Agile Therapeutic, Cipla Limited, Glenmark Pharmaceuticals, Novartis AG, Sun Pharmaceutical Industries Ltd., Apothecus Pharmaceutical Corporation, Famy care, Mylan Laboratories

North America was the largest region in the hormonal contraceptives market share in 2024. Middle East is expected to be the fastest-growing region in the global hormonal contraceptives market analysis during the forecast period. The regions covered in the hormonal contraceptives market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

The countries covered in the hormonal contraceptives market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Italy, Canada, Spain

The hormonal contraceptive market includes revenues earned by entities by blocking the release of eggs from the ovaries and thinning the lining of the uterus to prevent pregnancy. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Hormonal Contraceptives Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on hormonal contraceptives market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

• Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
• Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
• Create regional and country strategies on the basis of local data and analysis.
• Identify growth segments for investment.
• Outperform competitors using forecast data and the drivers and trends shaping the market.
• Understand customers based on the latest market shares.
• Benchmark performance against key competitors.
• Suitable for supporting your internal and external presentations with reliable high quality data and analysis
• Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
• All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for hormonal contraceptives ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The hormonal contraceptives market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

• The market characteristics section of the report defines and explains the market.
• The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
• The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.

• Market segmentations break down the market into sub markets.
• The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
• The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
• The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

• Markets Covered:1) By Product : Pills, Injectable Birth Control, Vaginal Rings, Others
• 2) By End User : Hospitals, Homecare Settings, Gynecology Centers, Clinics, Ambulatory Surgical Centers
• 3) By Hormones : Progestin-Only, Combined Hormones
• 4) By Distribution Channel : Drug Stores, Gynecology Or Fertility Clinics, E-Commerce, Other Distribution Channels
• Subsegments:
• 1) By Pills: Combined Oral Contraceptives (COCs); Progestin-Only Pills (POPs); Emergency Contraceptive Pills
• 2) By Injectable Birth Control: Depot Medroxyprogesterone Acetate (DMPA); Combination Injectable Contraceptives; Subdermal Implants
• 3) By Vaginal Rings: NuvaRing; Annovera; Other Hormonal Vaginal Rings
• 4) By Others: Transdermal Patches; Intrauterine Devices (IUDs) with Hormones; Hormonal Implants; Contraceptive Tablets For Men
• Companies Mentioned: Bayer AG; Merck & Co. Inc; Viatris; Gedeon Richter; AbbVie
• Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
• Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
• Time series: Five years historic and ten years forecast.
• Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
• Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
• Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
• Delivery format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Hormonal Contraceptives Market Characteristics

3. Hormonal Contraceptives Market Trends And Strategies

4. Hormonal Contraceptives Market - Macro Economic Scenario including the impact of Interest Rates, Inflation, Geopolitics and Covid And Recovery on the Market

5. Global Hormonal Contraceptives Growth Analysis And Strategic Analysis Framework

• 5.1. Global Hormonal Contraceptives PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
• 5.2. Analysis Of End Use Industries
• 5.3. Global Hormonal Contraceptives Market Growth Rate Analysis
• 5.4. Global Hormonal Contraceptives Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
• 5.5. Global Hormonal Contraceptives Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
• 5.6. Global Hormonal Contraceptives Total Addressable Market (TAM)

6. Hormonal Contraceptives Market Segmentation

• 6.1. Global Hormonal Contraceptives Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Pills
• Injectable Birth Control
• Vaginal Rings
• Other Products
• 6.2. Global Hormonal Contraceptives Market, Segmentation By End Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Hospitals
• Homecare Settings
• Gynaecology Centers
• Clinics
• Ambulatory Surgical Centers
• 6.3. Global Hormonal Contraceptives Market, Segmentation By Hormones, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Progestin-Only
• Combined Hormones
• 6.4. Global Hormonal Contraceptives Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Drug Stores
• Gynaecology/ Fertility Clinics
• E-Commerce
• Other Distribution Channels
• 6.5. Global Hormonal Contraceptives Market, Sub-Segmentation Of Pills, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Combined Oral Contraceptives (COCs)
• Progestin-Only Pills (POPs)
• Emergency Contraceptive Pills
• 6.6. Global Hormonal Contraceptives Market, Sub-Segmentation Of Injectable Birth Control, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Depot Medroxyprogesterone Acetate (DMPA)
• Combination Injectable Contraceptives
• Subdermal Implants
• 6.7. Global Hormonal Contraceptives Market, Sub-Segmentation Of Vaginal Rings, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• NuvaRing
• Annovera
• Other Hormonal Vaginal Rings
• 6.8. Global Hormonal Contraceptives Market, Sub-Segmentation Of Other Products, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Transdermal Patches
• Intrauterine Devices (IUDs) with Hormones
• Hormonal Implants
• Contraceptive Tablets For Men

7. Hormonal Contraceptives Market Regional And Country Analysis

• 7.1. Global Hormonal Contraceptives Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 7.2. Global Hormonal Contraceptives Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Hormonal Contraceptives Market

• 8.1. Asia-Pacific Hormonal Contraceptives Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 8.2. Asia-Pacific Hormonal Contraceptives Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.3. Asia-Pacific Hormonal Contraceptives Market, Segmentation By End Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.4. Asia-Pacific Hormonal Contraceptives Market, Segmentation By Hormones, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Hormonal Contraceptives Market

• 9.1. China Hormonal Contraceptives Market Overview
• 9.2. China Hormonal Contraceptives Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.3. China Hormonal Contraceptives Market, Segmentation By End Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.4. China Hormonal Contraceptives Market, Segmentation By Hormones, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Hormonal Contraceptives Market

• 10.1. India Hormonal Contraceptives Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.2. India Hormonal Contraceptives Market, Segmentation By End Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.3. India Hormonal Contraceptives Market, Segmentation By Hormones, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Hormonal Contraceptives Market

• 11.1. Japan Hormonal Contraceptives Market Overview
• 11.2. Japan Hormonal Contraceptives Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.3. Japan Hormonal Contraceptives Market, Segmentation By End Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.4. Japan Hormonal Contraceptives Market, Segmentation By Hormones, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Hormonal Contraceptives Market

• 12.1. Australia Hormonal Contraceptives Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.2. Australia Hormonal Contraceptives Market, Segmentation By End Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.3. Australia Hormonal Contraceptives Market, Segmentation By Hormones, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Hormonal Contraceptives Market

• 13.1. Indonesia Hormonal Contraceptives Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.2. Indonesia Hormonal Contraceptives Market, Segmentation By End Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.3. Indonesia Hormonal Contraceptives Market, Segmentation By Hormones, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Hormonal Contraceptives Market

• 14.1. South Korea Hormonal Contraceptives Market Overview
• 14.2. South Korea Hormonal Contraceptives Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.3. South Korea Hormonal Contraceptives Market, Segmentation By End Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.4. South Korea Hormonal Contraceptives Market, Segmentation By Hormones, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Hormonal Contraceptives Market

• 15.1. Western Europe Hormonal Contraceptives Market Overview
• 15.2. Western Europe Hormonal Contraceptives Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.3. Western Europe Hormonal Contraceptives Market, Segmentation By End Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.4. Western Europe Hormonal Contraceptives Market, Segmentation By Hormones, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Hormonal Contraceptives Market

• 16.1. UK Hormonal Contraceptives Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.2. UK Hormonal Contraceptives Market, Segmentation By End Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.3. UK Hormonal Contraceptives Market, Segmentation By Hormones, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Hormonal Contraceptives Market

• 17.1. Germany Hormonal Contraceptives Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.2. Germany Hormonal Contraceptives Market, Segmentation By End Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.3. Germany Hormonal Contraceptives Market, Segmentation By Hormones, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Hormonal Contraceptives Market

• 18.1. France Hormonal Contraceptives Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.2. France Hormonal Contraceptives Market, Segmentation By End Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.3. France Hormonal Contraceptives Market, Segmentation By Hormones, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Hormonal Contraceptives Market

• 19.1. Italy Hormonal Contraceptives Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.2. Italy Hormonal Contraceptives Market, Segmentation By End Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.3. Italy Hormonal Contraceptives Market, Segmentation By Hormones, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Hormonal Contraceptives Market

• 20.1. Spain Hormonal Contraceptives Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.2. Spain Hormonal Contraceptives Market, Segmentation By End Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.3. Spain Hormonal Contraceptives Market, Segmentation By Hormones, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Hormonal Contraceptives Market

• 21.1. Eastern Europe Hormonal Contraceptives Market Overview
• 21.2. Eastern Europe Hormonal Contraceptives Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.3. Eastern Europe Hormonal Contraceptives Market, Segmentation By End Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.4. Eastern Europe Hormonal Contraceptives Market, Segmentation By Hormones, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Hormonal Contraceptives Market

• 22.1. Russia Hormonal Contraceptives Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.2. Russia Hormonal Contraceptives Market, Segmentation By End Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.3. Russia Hormonal Contraceptives Market, Segmentation By Hormones, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Hormonal Contraceptives Market

• 23.1. North America Hormonal Contraceptives Market Overview
• 23.2. North America Hormonal Contraceptives Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.3. North America Hormonal Contraceptives Market, Segmentation By End Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.4. North America Hormonal Contraceptives Market, Segmentation By Hormones, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Hormonal Contraceptives Market

• 24.1. USA Hormonal Contraceptives Market Overview
• 24.2. USA Hormonal Contraceptives Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.3. USA Hormonal Contraceptives Market, Segmentation By End Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.4. USA Hormonal Contraceptives Market, Segmentation By Hormones, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Hormonal Contraceptives Market

• 25.1. Canada Hormonal Contraceptives Market Overview
• 25.2. Canada Hormonal Contraceptives Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.3. Canada Hormonal Contraceptives Market, Segmentation By End Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.4. Canada Hormonal Contraceptives Market, Segmentation By Hormones, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Hormonal Contraceptives Market

• 26.1. South America Hormonal Contraceptives Market Overview
• 26.2. South America Hormonal Contraceptives Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.3. South America Hormonal Contraceptives Market, Segmentation By End Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.4. South America Hormonal Contraceptives Market, Segmentation By Hormones, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Hormonal Contraceptives Market

• 27.1. Brazil Hormonal Contraceptives Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.2. Brazil Hormonal Contraceptives Market, Segmentation By End Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.3. Brazil Hormonal Contraceptives Market, Segmentation By Hormones, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Hormonal Contraceptives Market

• 28.1. Middle East Hormonal Contraceptives Market Overview
• 28.2. Middle East Hormonal Contraceptives Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.3. Middle East Hormonal Contraceptives Market, Segmentation By End Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.4. Middle East Hormonal Contraceptives Market, Segmentation By Hormones, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Hormonal Contraceptives Market

• 29.1. Africa Hormonal Contraceptives Market Overview
• 29.2. Africa Hormonal Contraceptives Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.3. Africa Hormonal Contraceptives Market, Segmentation By End Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.4. Africa Hormonal Contraceptives Market, Segmentation By Hormones, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Hormonal Contraceptives Market Competitive Landscape And Company Profiles

• 30.1. Hormonal Contraceptives Market Competitive Landscape
• 30.2. Hormonal Contraceptives Market Company Profiles
  • 30.2.1. Bayer AG Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.2. Merck & Co. Inc Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.3. Viatris Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.4. Gedeon Richter Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.5. AbbVie Overview, Products and Services, Strategy and Financial Analysis

31. Hormonal Contraceptives Market Other Major And Innovative Companies

• 31.1. Pfizer
• 31.2. Teva Pharmaceuticals
• 31.3. Mayne Pharma Group Limited
• 31.4. Lupin Limited
• 31.5. HLL Lifecare Limited
• 31.6. Amneal Pharmaceuticals
• 31.7. DKT International
• 31.8. Piramal Pharma Limited
• 31.9. Allergan
• 31.10. Afaxys Inc.
• 31.11. Agile Therapeutic
• 31.12. Cipla Limited
• 31.13. Glenmark Pharmaceuticals
• 31.14. Novartis AG
• 31.15. Sun Pharmaceutical Industries Ltd.

32. Global Hormonal Contraceptives Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Hormonal Contraceptives Market

34. Recent Developments In The Hormonal Contraceptives Market

35. Hormonal Contraceptives Market High Potential Countries, Segments and Strategies

• 35.1 Hormonal Contraceptives Market In 2029 - Countries Offering Most New Opportunities
• 35.2 Hormonal Contraceptives Market In 2029 - Segments Offering Most New Opportunities
• 35.3 Hormonal Contraceptives Market In 2029 - Growth Strategies
  • 35.3.1 Market Trend Based Strategies
  • 35.3.2 Competitor Strategies

36. Appendix

• 36.1. Abbreviations
• 36.2. Currencies
• 36.3. Historic And Forecast Inflation Rates
• 36.4. Research Inquiries
• 36.5. The Business Research Company
• 36.6. Copyright And Disclaimer